Select Page

CURRENT TRIALS

We are currently performing several studies on RA, Psoriatic Arthritis, Lupus, and Ankylosing Spondylitis. Summaries of several of these studies which are currently recruiting (accepting new patients) can be found on the FDA database of research studies known as ClinicalTrials.gov. The specific links are as follows…

 

RA (Rheumatoid Arthritis)

  • Study 1 – Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  • Study 2 – Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
  • Study 3 – A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

SLE (Systemic Lupus Erythematosus)

  • Study 1 – A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (BRAVE II)
  • Study 2 – A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) (SLE-BRAVE-X)

AS (Ankylosing Spondylitis)

  • Study 1 – Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis (ASLeap)

About Us

Cincinnati Rheumatic Disease Study Group
10495 Montgomery Road, Suite 26
Cincinnati, OH 45242
(513) 559-2130

Connect With Us

1000 Patients Helped by 18 Rheumatologists Since 1991!

Copyright ©2019 - Cincinnati Rheumatic Disease Study Group. All rights reserved. Internet Presence by Main Street Marketing

About Us

Cincinnati Rheumatic Disease Study Group
10495 Montgomery Road, Suite 26
Cincinnati, OH 45242
(513) 559-2130

Connect With Us

1000 Patients Helped by 18 Rheumatologists Since 1991!

 

Copyright ©2019 - Cincinnati Rheumatic Disease Study Group. All rights reserved.
Internet Presence by Main Street Marketing